BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma (clinicaltrials.gov) - Oct 3, 2026 - P2 | N=43 | Recruiting | Sponsor: Mayo Clinic | Trial completion date: Dec 2028 ➔ Feb 2028 | Trial primary completion date: Dec 2028 ➔ Feb 2027
Trial completion date • Trial primary completion date • Oncology • Pancreatic Adenocarcinoma • Pancreatic Cancer • Solid Tumor
|